Related Experiment Video
Updated: May 16, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
The EU-ADR Web Platform: delivering advanced pharmacovigilance tools
José Luis Oliveira1, Pedro Lopes, Tiago Nunes
1DETI/IEETA, University of Aveiro, Aveiro, Portugal. jlo@ua.pt
Pharmacoepidemiology and Drug Safety
|December 5, 2012
Summary
The EU-ADR Web Platform enhances drug safety by analyzing real-world data for adverse drug reactions. This tool aids pharmacovigilance researchers in identifying high-risk drug-event relationships for better drug assessment.
Area of Science:
- Pharmacovigilance and Bioinformatics
Background:
- Pharmacovigilance methods have significantly advanced, making post-market drug assessment crucial.
- Spontaneous reporting systems and health databases are key for collecting real-world drug data.
- The EU-ADR Web Platform was developed to improve access and analysis of this data.
Purpose of the Study:
- To create a centralized platform for accessing, monitoring, and exploring pharmacovigilance data.
- To enable in-depth analysis of adverse drug reaction risks.
- To facilitate the identification of high-risk drug-event relationships.
Main Methods:
- Utilizing millions of electronic health records from a large-scale European initiative (EU-ADR project).
- Mining health records for specific drug events and correlating them with literature, protein, and pathway data.
- Employing advanced distributed computing for data mining and statistical analysis to rank drug-event pairs and identify potential risks.
Main Results:
- The EU-ADR Web Platform provides an open workspace for integrated pharmacovigilance dataset analysis.
- Researchers can access diverse tools from multiple partners in a single environment.
- The platform supports standalone and batch analysis of custom datasets, enabling statistical substantiation of drug-event pairs.
Conclusions:
- A novel workspace has been developed to elucidate the biological pathways of adverse drug reactions.
- This tool is specifically designed for the pharmacovigilance community.
- The EU-ADR Web Platform is accessible online for researchers.
Related Concept Videos
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.